Physician profile
Flory M Kreutter
NPI 1538115134
$13,308.48
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,147 · 2021: $92.03.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $12,465.36 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $317.02 | 2019-2021 | |
| Amgen INC. | $108.84 | 2019-2021 | |
| Allergan, INC. | $102.04 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $98.93 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.26 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.66 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $26.86 | 2021 | |
| Seqirus USA INC | $18.97 | 2020 | |
| Vanda Pharmaceuticals INC. | $17.50 | 2020 | |
| Sanofi Pasteur INC. | $15.50 | 2019 | |
| Gilead Sciences, INC. | $14.78 | 2020 | |
| Ethicon US, LLC | $13.91 | 2019 | |
| Novo Nordisk INC | $12.35 | 2021 | |
| Aytu Biopharma, INC. | $11.66 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $10.84 | 2019 |
5 companies reported research payments only; those appear in the research section below.
Research and ownership
$68.92 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Flory Kreutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.